Howland Capital Management LLC Biogen Inc. Transaction History

Howland Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 28, 2021	SELL	$259.0 - $414.71 $207,200 - $331,768	-800 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$242.95 - $284.63 $194,360 - $227,704	800 New	800 $224,000
Q4 2020 Jan 26, 2021	SELL	$236.26 - $355.63 $243,347 - $366,298	-1,030 Closed	0 $0
Q1 2020 Apr 13, 2020	SELL	$268.85 - $341.04 $2,688 - $3,410	-10 Reduced 0.96%	1,030 $325,000
Q4 2019 Jan 23, 2020	BUY	$220.06 - $304.07 $19,805 - $27,366	90 Added 9.47%	1,040 $309,000
Q3 2019 Oct 22, 2019	BUY	$217.44 - $243.88 $4,348 - $4,877	20 Added 2.15%	950 $221,000
Q1 2019 Apr 22, 2019	SELL	$216.71 - $338.96 $9,318 - $14,575	-43 Reduced 4.42%	930 $220,000
Q3 2018 Oct 25, 2018	SELL	$293.51 - $383.83 $587 - $767	-2 Reduced 0.21%	973 $344,000
Q1 2018 May 02, 2018	BUY	$260.13 - $367.91 $520 - $735	2 Added 0.21%	975 $267,000
Q3 2017 Oct 30, 2017	BUY	$281.15 - $329.69 $273,558 - $320,788	973	973 $305,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Howland Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Howland Capital Management LLC with notifications on news.